Emil Kongshj Larsen, executive vice president of international operations at Novo Nordisk, said in a press release, This approval is another important step in helping people living with obesity reach very significant weight loss
The increased use of GLP-1 medications presents an exciting opportunity to support Americans managing diabetes and weight loss, as well as those seeking to lead a healthier lifestyle, said Bob Nolan, vice president of demand science at Conagra Brands
The 90-Day Milestone: Why 3 Months Matters The three-month mark is not an arbitrary number in the world of wellness
Protein helps preserve your muscle mass and keeps your blood sugar stable, reducing the risk of energy crashes
Take stock of your diet: Have your eating patterns evolved with your body
What happens when we stop GLP-1 receptor agonists